Noninferiority Trial Of Sirolimus With Ascorbic Acid Versus Everolimus in All-comers

NCT07566091 · clinicaltrials.gov ↗

NA

Phase

NOT_YET_RECRUITING

Status

2034

Enrollment

OTHER

Sponsor class

Conditions

Coronary Artery Disease

Interventions

DEVICE: Sirolimus-Ascorbic Acid Eluting Stent
DEVICE: Everolimus-Eluting Stent

Sponsor

Jung-min Ahn

Collaborators

[object Object]